ジェネラリストのための神経疾患の診かた

各論1 物忘れ

P.8 掲載の参考文献

2) Nasreddine ZS, Phillips NA, Bedirian V, et al. The Montreal Cognitive Assessment, MoCA : a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005 ; 53 : 695-9. [PMID : 15817019]

 

3) Petersen RC. Clinical practice. Mild cognitive impairment. N Engl J Med. 2011 ; 364 : 2227-34. [PMID : 21651394]

 

4) Russ TC, Morling JR. Cholinesterase inhibitors for mild cognitive impairment. Cochrane Database Syst Rev. 2012 ; 9 : CD009132. [PMID : 22972133]

 

P.9 掲載の参考文献

5) Fink HA, Jutkowitz E, McCarten JR, et al. Pharmacologic interventions to prevent cognitive decline, mild cognitive impairment, and clinical Alzheimer-type dementia : a systematic review. Ann Intern Med. 2018 ; 168 : 39-51. [PMID : 29255847]

 

6) Petersen RC, Lopez O, Armstrong MJ, et al. Practice guideline update summary : Mild cognitive impairment : Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology. 2018 ; 90 : 126-35. [PMID : 29282327

 

P.10 掲載の参考文献

7) Xu H, Yang R, Qi X, et al. Association of lifespan cognitive reserve indicator with dementia risk in the presence of brain pathologies. JAMA Neurol. 2019. [Epub ahead of print] [PMID : 31302677]

 

デヴィッド・スノウドン. 藤井留美, 訳. 100歳の美しい脳-アルツハイマー病解明に手をさしのべた修道女たち. DHC ; 2004.

 

8) アルツハイマー その生涯とアルツハイマー病発見の奇跡 (コンラート・マウアー/ウルリケ・マウアー, 共著. 新井公人, 監訳. 喜多内・オルブリッヒゆみ/羽田・クノーブラオホ眞澄, 訳)

 

9) 臨床医が語る 認知症と生きるということ (岩田誠, 著. 日本評論社)

 

ドイツ精神医学の原典を読む (池村義明, 著. 医学書院)

 

P.11 掲載の参考文献

10) Warren JD, Fletcher PD, Golden HL. The paradox of syndromic diversity in Alzheimer disease. Nat Rev Neurol. 2012 ; 8 : 451-64. [PMID : 22801974]

 

11) Nelson PT, Dickson DW, Trojanowski JQ, et al. Limbic-predominant age-related TDP-43 encephalopathy (LATE) : consensus working group report. Brain. 2019 ; 142 : 1503-27. [PMID : 31039256]

 

P.12 掲載の参考文献

16) https://solidarites-sante.gouv.fr/actualites/presse/communiques-de-presse/article/l-interet-therapeutique-des-medicaments-de-la-maladie-d-alzheimer-n-est-pas

 

17) Raina P, Santaguida P, Ismaila A, et al. Effectiveness of cholinesterase inhibitors and memantine for treating dementia : evidence review for a clinical practice guideline. Ann Intern Med. 2008 ; 148 : 379-97. [PMID : 18316756]

 

P.13 掲載の参考文献

Schenck CH, Boeve BF, Mahowald MW. Delayed emergence of a parkinsonian disorder or dementia in 81% of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder : a 16-year update on a previously reported series. Sleep Med. 2013 ; 14 : 744-8. [PMID : 23347909]

PubMed

Iranzo A, Tolosa E, Gelpi E, et al. Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder : an observational cohort study. Lancet Neurol. 2013 ; 12 : 443-53. [PMID : 23562390]

 

19) 松原知康, 井口正寛. 7. 認知症 : ホスピタリストの対応範囲を意識しながらPros×Consで迫る! Hospitalist. 2019 ; 7 : 1.

 

20) Mayo MC, Bordelon Y. Dementia with Lewy bodies. Semin Neurol. 2014 ; 34 : 182-8. [PMID : 24963677]

 

21) Hogl B, Stefani A, Videnovic A. Idiopathic REM sleep behaviour disorder and neurodegeneration-an update. Nat Rev Neurol. 2018 ; 14 : 40-55. [PMID : 29170501]

 

P.15 掲載の参考文献

オリヴァー・サックス. 大田直子, 訳. 見てしまう人びと 幻覚の脳科学. 東京 : 早川書房 ; 2014.

 

Pagano G, Rengo G, Pasqualetti G, et al. Cholinesterase inhibitors for Parkinson's disease : a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2015 ; 86 : 767-73. [PMID : 25224676]

 

23) 「オリバー・サックス : 幻覚が解き明かす人間のマインド」https://www.ted.com/talks/oliver_sacks_what_hallucination_reveals_about_our_minds?language=ja

 

24) Rolinski M, Fox C, Maidment I, et al. Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease. Cochrane Database Syst Rev. 2012 ; CD006504. [PMID : 22419314]

 

Wang HF, Yu JT, Tang SW, et al. Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies : systematic review with meta-analysis and trial sequential analysis. J Neurol Neurosurg Psychiatry. 2015 ; 86 : 135-43. [PMID : 24828899]

 

25) Siclari F, Baird B, Perogamvros L, et al. The neural correlates of dreaming. Nat Neurosci. 2017 ; 20 : 872-8. [PMID : 28394322

 

P.16 掲載の参考文献

26) Josephs KA. Capgras syndrome and its relationship to neurodegenerative disease. Arch Neurol. 2007 ; 64 : 1762-6. [PMID : 18071040]

 

27) Jankovic J, Goodman I, Safirstein B, et al. Safety and tolerability of multiple ascending doses of PRX002/RG7935, an anti-α-synuclein monoclonal antibody, in patients with Parkinson disease : a randomized clinical trial. JAMA Neurol. 2018 ; 75 : 1206-14. [PMID : 29913017]

 

Brys M, Fanning L, Hung S, et al. Randomized phase I clinical trial of anti-α-synuclein antibody BIIB054. Mov Disord. 2019 ; 34 : 1154-63. [PMID : 31211448]

 

P.17 掲載の参考文献

29) Kavirajan H, Schneider LS. Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia : a meta-analysis of randomised controlled trials. Lancet Neurol. 2007 ; 6 : 782-92. [PMID : 17689146]

 

30) Dementia : assessment, management and support for people living with dementia and their carers https://www.nice.org.uk/guidance/ng97/chapter/Recommendations#pharmacological-interventions-for-dementia (2019年3月12日アクセス)

 

P.19 掲載の参考文献

34) Miyakawa T, Inoue K, Iseki E, et al. Japanese Creutzfeldt-Jakob disease patients exhibiting high incidence of the E200K PRNP mutation and located in the basin of a river. Neurol Res. 1998 ; 20 : 684-8. [PMID : 9864731]

 

35) Puoti G, Bizzi A, Forloni G, et al. Sporadic human prion diseases : molecular insights and diagnosis. Lancet Neurol. 2012 ; 11 : 618-28. [PMID : 22710755]

 

36) 日本神経学会, 監修. プリオン病診療ガイドライン 2017. http://prion.umin.jp/guideline_guideline_2017.pdf (2019年3月12日アクセス) http://prion.umin.jp/guideline/guideline_2020temp.pdf

 

P.20 掲載の参考文献

38) 厚生労働科学研究費補助金・難治性疾患克服研究事業 プリオン病及び遅発性ウイルス感染症に関する調査研究班. プリオン病感染予防ガイドライン (2008年版). http://prion.umin.jp/guideline/cjd_2008all.pdf (2019年3月12日アクセス)

 

P.21 掲載の参考文献

39) Armstrong MJ, Litvan I, Lang AE, et al. Criteria for the diagnosis of corticobasal degeneration. Neurology. 2013 ; 80 : 496-503. [PMID : 23359374]

 

P.22 掲載の参考文献

40) Mori E, Ishikawa M, Kato T, et al. Guidelines for management of idiopathic normal pressure hydrocephalus : second edition. Neurol Med Chir (Tokyo). 2012 ; 52 (11) : 775-809. [PMID : 23183074]

 

41) Mori E, Ishikawa M, Kato T, et al. Guidelines for management of idiopathic normal pressure hydrocephalus : second edition. Neurol Med Chir (Tokyo). 2012 ; 52 (11) : 775-809. [PMID : 23183074]

 

P.23 掲載の参考文献

43) Halperin JJ, Kurlan R, Schwalb JM, et al. Practice guideline : Idiopathic normal pressure hydrocephalus : Response to shunting and predictors of response : Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology. 2015 ; 85 : 2063-71. [PMID : 26644048]

 

44) コンラート・マウアー/ウルリケ・マウアー, 共著. 新井公人, 監訳. 喜多内・オルブリッヒゆみ, 羽田・クノーブラオホ眞澄, 訳. アルツハイマー その生涯とアルツハイマー病発見の奇跡. 東京 : 保健同人社 ; 2004.

 

P.24 掲載の参考文献

Caine D, Halliday GM, Kril JJ, et al. Operational criteria for the classification of chronic alcoholics : identification of Wernicke's encephalopathy. J Neurol Neurosurg Psychiatry. 1997 ; 62 : 51-60. [PMID : 9010400]

 

45) Galvin R, Brathen G, Ivashynka A, et al. EFNS guidelines for diagnosis, therapy and prevention of Wernicke encephalopathy. Eur J Neurol. 2010 ; 17 : 1408-18. [PMID : 20642790]

 

46) Harper CG, Giles M, Finlay-Jones R. Clinical signs in the Wernicke-Korsakoff complex : a retrospective analysis of 131 cases diagnosed at necropsy. J Neurol Neurosurg Psychiatry. 1986 ; 49 : 341-5. [PMID : 3701343]

 

47) Galvin R, Brathen G, Ivashynka A, et al. EFNS guidelines for diagnosis, therapy and prevention of Wernicke encephalopathy. Eur J Neurol. 2010 ; 17 : 1408-18. [PMID : 20642790]

 

49) Kono S, Miyajima H, Yoshida K, et al. Mutations in a thiamine-transporter gene and Wernicke's-like encephalopathy. N Engl J Med. 2009 ; 360 : 1792-4. [PMID : 19387023]

 

P.25 掲載の参考文献

50) Devalia V, Hamilton MS, Molloy AM ; British Committee for Standards in Haematology. Guidelines for the diagnosis and treatment of cobalamin and folate disorders. Br J Haematol. 2014 ; 166 : 496-513. [PMID : 24942828]

 

P.26 掲載の参考文献

51) Hunt A, Harrington D, Robinson S. Vitamin B12 deficiency. BMJ. 2014 ; 349 : g5226. [PMID : 25189324]

 

52) Stabler SP. Clinical practice. Vitamin B12 deficiency. N Engl J Med. 2013 ; 368 : 149-60. [PMID : 23301732]

 

54) Devalia V, Hamilton MS, Molloy AM ; British Committee for Standards in Haematology. Guidelines for the diagnosis and treatment of cobalamin and folate disorders. Br J Haematol. 2014 ; 166 : 496-513. [PMID : 24942828]

 

55) Wang H, Li L, Qin LL, et al. Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency. Cochrane Database Syst Rev. 2018 ; 3 : CD004655. [PMID : 29543316]

 

P.27 掲載の参考文献

57) Hunt A, Harrington D, Robinson S. Vitamin B12 deficiency. BMJ. 2014 ; 349 : g5226. [PMID : 25189324]

 

58) Reynolds E. Vitamin B12, folic acid, and the nervous system. Lancet Neurol. 2006 ; 5 : 949-60. [PMID : 17052662]

 

59) Devalia V, Hamilton MS, Molloy AM ; British Committee for Standards in Haematology. Guidelines for the diagnosis and treatment of cobalamin and folate disorders. Br J Haematol. 2014 ; 166 : 496-513. [PMID : 24942828]

 

P.28 掲載の参考文献

Walter O, Treiner E, Bonneville F, et al. Treatment of progressive multifocal leukoencephalopathy with nivolumab. N Engl J Med. 2019 ; 380 : 1674-6. [PMID : 30969500]

 

Rauer S, Marks R, Urbach H, et al. Treatment of progressive multifocal leukoencephalopathy with pembrolizumab. N Engl J Med. 2019 ; 380 : 1676-7. [PMID : 30969507]

 

Cortese I, Muranski P, Enose-Akahata Y, et al. Pembrolizumab treatment for progressive multifocal leukoencephalopathy. N Engl J Med. 2019 ; 380 : 1597-605. [PMID : 30969503]

 

62) Muftuoglu M, Olson A, Marin D, et al. Allogeneic BK virus-specific T cells for progressive multifocal leukoencephalopathy. N Engl J Med. 2018 ; 379 : 1443-51. [PMID : 30304652]

 

63) Bucelli RC, Ances BM. Diagnosis and evaluation of a patient with rapidly progressive dementia. Mo Med. 2013 ; 110 : 422-8. [PMID : 24279195]

 

64) Bartsch T, Butler C. Transient amnesic syndromes. Nat Rev Neurol. 2013 ; 9 : 86-97. [23296343]

PubMed

P.30 掲載の参考文献

65) Bartsch T, Butler C. Transient amnesic syndromes. Nat Rev Neurol. 2013 ; 9 : 86-97. [23296343]

PubMed

P.31 掲載の参考文献

66) Michel P, Beaud V, Eskandari A, et al. Ischemic amnesia : causes and outcome. Stroke. 2017 ; 48 : 2270-3. [PMID : 28584000]

 

P.32 掲載の参考文献

Creavin ST, Wisniewski S, Noel-Storr AH, et al. Mini-Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care populations. Cochrane Database Syst Rev. 2016 ; 1 : CD011145. [PMID : 26760674]

 

Tombaugh TN, McIntyre NJ. The mini-mental state examination : a comprehensive review. J Am Geriatr Soc. 1992 ; 40 : 922-35. [PMID : 1512391]

 

68) Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 ; 12 : 189-98. [PMID : 1202204]

 

P.35 掲載の参考文献

69) Nakamura A, Kaneko N, Villemagne VL, et al. High performance plasma amyloid-β biomarkers for Alzheimer's disease. Nature. 2018 ; 554 : 249-54. [PMID : 29420472]

 

70) Schindler SE, Bollinger JG, Ovod V, et al. High-precision plasma β-amyloid 42-40 predicts current and future brain amyloidosis. Neurology. 2019. [Epub ahead of print] [PMID : 31371569]

 

P.37 掲載の参考文献

71) Lin CY, Kuo SH. Cerebellar Ataxia and Hearing Impairment. JAMA Neurol. 2017 ; 74 : 243-4. [PMID : 27918770]

 

72) Sone J, Mori K, Inagaki T, et al. Clinicopathological features of adult-onset neuronal intranuclear inclusion disease. Brain. 2016 ; 139 : 3170-86. [PMID : 27797808]

 

P.38 掲載の参考文献

Ishiura H, Shibata S, Yoshimura J, et al. Noncoding CGG repeat expansions in neuronal intranuclear inclusion disease, oculopharyngodistal myopathy and an overlapping disease. Nat Genet. 2019 ; 51 : 1222-32. [PMID : 31332380]

 

73) Sone J, Mitsuhashi S, Fujita A, et al. Long-read sequencing identifies GGC repeat expansions in NOTCH2NLC associated with neuronal intranuclear inclusion disease. Nat Genet. 2019 ; 51 : 1215-21. [PMID : 31332381]

 

P.39 掲載の参考文献

75) Thomas AJ, Attems J, Colloby SJ, et al. Autopsy validation of 123I-FP-CIT dopaminergic neuroimaging for the diagnosis of DLB. Neurology. 2017 ; 88 : 276-83. [PMID : 27940650]

 

P.40 掲載の参考文献

76) Lin CY, Kuo SH. Cerebellar ataxia and hearing impairment. JAMA Neurol. 2017 ; 74 : 243-4. [PMID : 27918770]

 

77) 日本神経学会, 監修. プリオン病診療ガイドライン 2017. http://prion.umin.jp/guideline/guideline_2017.pdf (2019年3月12日アクセス)

 

P.41 掲載の参考文献

78) Hanseeuw BJ, Betensky RA, Jacobs HIL, et al. Association of amyloid and tau with cognition in preclinical Alzheimer disease : a longitudinal study. JAMA Neurol. 2019. [Epub ahead of print] [PMID : 31157827]

 

P.42 掲載の参考文献

80) Orru CD, Bongianni M, Tonoli G, et al. A test for Creutzfeldt-Jakob disease using nasal brushings. N Engl J Med. 2014 ; 371 : 519-29. [PMID : 25099576].

 

P.43 掲載の参考文献

82) Moda F, Gambetti P, Notari S, et al. Prions in the urine of patients with variant Creutzfeldt-Jakob disease. N Engl J Med. 2014 ; 371 : 530-9. [PMID : 25099577]

 

83) Bongianni M, Orru C, Groveman BR, et al. Diagnosis of human prion disease using real-time quaking-induced conversion testing of olfactory mucosa and cerebrospinal fluid samples. JAMA Neurol. 2017 ; 74 : 155-62. [PMID : 27942718]

 

84) http://prion.umin.jp/survey/cjd.html (2019年3月12日アクセス)

 

85) Lin CY, Kuo SH. Cerebellar ataxia and hearing impairment. JAMA Neurol. 2017 ; 74 : 243-4. [PMID : 27918770]

 

P.46 掲載の参考文献

87) 「アデュカヌマブ 臨床第III相試験で得られた大規模データセットの新たな解析結果に基づき, アルツハイマー病を対象とした新薬承認申請を予定」https://www.eisai.co.jp/news/2019/news201979.html

 

88) 「バイオジェンとエーザイ, アルツハイマー病を対象としたアデュカヌマブの臨床第III相国際共同試験 (ENGAGE 試験, EMERGE 試験) を中止. 独立データモニタリングコミッティが主要評価項目達成の可能性が低いと判断」https://www.eisai.co.jp/news/2019/pdf/news201917pdf.pdf

 

P.47 掲載の参考文献

89) 「Third Quarter 2019 Financial Results and Business Update」http://investors.biogen.com/static-files/40565136-b61f-4473-9e58-9be769bbac6c

 

90) O'Bryant SE, Waring SC, Cullum CM, et al. Staging dementia using Clinical Dementia Rating Scale Sum of Boxes scores : a Texas Alzheimer's research consortium study. Arch Neurol. 2008 ; 65 : 1091-5. [PMID : 18695059]

 

P.50 掲載の参考文献

1) Alajouanine T. Aphasia and artistic realization. Brain. 1948 ; 71 : 229-41. [PMID : 18099548]

 

2) Mesulam MM. Slowly progressive aphasia without generalized dementia. Ann Neurol. 1982 ; 11 : 592-8. [PMID : 7114808]

 

P.51 掲載の参考文献

岩田誠. 脳と音楽. 東京 : メディカルレビュー社 ; 2001.

 

佐藤正之. ラヴェル : 脳に閉じ込められた音楽. 神経内科. 2015 ; 82 : 187-94.

 

Alonso RJ, Pascuzzi RM. Ravel's neurological illness. Semin Neurol. 1999 ; 19 Suppl 1 : 53-7. [PMID : 10718529]

 

Amaducci L, Grassi E, Boller F. Maurice Ravel and right-hemisphere musical creativity : influence of disease on his last musical works? Eur J Neurol. 2002 ; 9 : 75-82. [PMID : 11784380]

 

ジョン・オシエー. 菅野弘久, 訳. 音楽と病. 東京 : 法政大学出版局 ; 1996.

 

P.52 掲載の参考文献

1) Brown-Sequard CE. Note on the effects produced on man by subcutaneous injections of a liquid obtained from the testicles of animals. Lancet. 1889 ; 134 : 105-7.

 

Kunikullaya UK, Ananthakrishnan V, Goturu J. Robert Tigerstedt and the discovery of renin-a revisit. Int J Cardiol. 2012 ; 158 : 1-5. [PMID : 22133471]

 

Tigerstedt R, Bergman PG. Niere und kreislauf. Scand Arch Physiol. 1898 ; 8 : 223-71.

 

荒川規矩男, 編. 高血圧研究の偉人達. 東京 : 先端医学社 ; 2005.

 

P.53 掲載の参考文献

2) Alajouanine T. Baillarger and Jackson : the principle of Baillarger-Jackson in aphasia. J Neurol Neurosurg Psychiatry 1960 ; 23 : 191-3. [PMID : 13792316]

 

P.54 掲載の参考文献

Kaitaro T. Biological and epistemological models of localization in the nineteenth century : from Gall to Charcot. J Hist Neurosci. 2001 ; 10 : 262-76. [PMID : 11770193]

 

Eling P, Whitaker H. History of aphasia : from brain to language. Handb Clin Neurol. 2010 ; 95 : 571-82. [PMID : 19892139]

 

McHenry LC Jr. 豊倉康夫, 萬年徹, 井上聖啓, 訳. 神経学の歴史 ヒポクラテスから近代まで. 東京 : 医学書院 ; 1969.

 

萬年甫, 岩田誠, 訳編. 神経学の源流 3 ブロカ. 東京 : 東京大学出版 ; 1992.

 

岩田誠. 脳とコミュニケーション. 東京 : 朝倉書店 ; 1987.

 

岩田誠. 脳とことば-言語の神経機構. 東京 : 共立出版 ; 1996.

 

P.55 掲載の参考文献

1) Omalu BI, DeKosky ST, Minster RL, et al. Chronic traumatic encephalopathy in a National Football League player. Neurosurgery. 2005 ; 57 : 128-34. [PMID : 15987548]

 

2) Omalu BI, DeKosky ST, Hamilton RL, et al. Chronic traumatic encephalopathy in a national football league player : part II. Neurosurgery. 2006 ; 59 : 1086-92. [PMID : 17143242]

 

3) New York Times : Expert Ties Ex-Player's Suicide to Brain Damage. http://www.nytimes.com/2007/01/18/sports/football/18waters.html [2019年10月19日アクセス]

 

P.56 掲載の参考文献

4) ジーン・マリー・ラスカス. 田口俊樹, 訳. コンカッション. 小学館文庫.

 

6) McKee AC, Gavett BE, Stern RA, et al. TDP-43 proteinopathy and motor neuron disease in chronic traumatic encephalopathy. J Neuropathol Exp Neurol. 2010 ; 69 : 918-29. [PMID : 20720505]

 

7) McKee AC, Cairns NJ, Dickson DW, et al. The first NINDS/NIBIB consensus meeting to define neuropathological criteria for the diagnosis of chronic traumatic encephalopathy. Acta Neuropathol. 2016 ; 131 : 75-86. [PMID : 26667418]

 

P.58 掲載の参考文献

8) Ling H, Morris HR, Neal JW, et al. Mixed pathologies including chronic traumatic encephalopathy account for dementia in retired association football (soccer) players. Acta Neuropathol. 2017 ; 133 : 337-52. [PMID : 28205009]

 

9) Mez J, Daneshvar DH, Kiernan PT, et al. Clinicopathological evaluation of chronic traumatic encephalopathy in players of American football. JAMA. 2017 ; 318 : 360-70. [PMID : 28742910]

 

10) Mackay DF, Russell ER, Stewart K, et al. Neurodegenerative disease mortality among former professional soccer players. N Engl J Med. 2019. [Epub ahead of print] [PMID : 31633894]

 

11) New York Times : U. S. Soccer, Resolving Lawsuit, Will Limit Headers for Youth Players. https://www.nytimes.com/2015/11/10/sports/soccer/us-soccer-resolving-lawsuitwill-limit-headers-for-youth-players.html [2017年11月1日アクセス]

 

12) McCrory P, Meeuwisse W, Dvorak J, et al. Consensus statement on concussion in sport-the 5th international conference on concussion in sport held in Berlin, October 2016. Br J Sports Med. 2017 ; 51 : 838-47. [PMID : 28446457]

 

P.59 掲載の参考文献

李啓充. 週間医学界新聞. 〔連載〕続 アメリカ医療の光と影 第261回 米スポーツ界を震撼させる変性脳疾患 (1). http://www.igaku-shoin.co.jp/paperDetail.do?id=PA03060_04 [2017年11月1日アクセス]

 

Asken BM, Sullan MJ, DeKosky ST, et al. Research Gaps and Controversies in Chronic Traumatic Encephalopathy : A Review. JAMA Neurol. 2017 ; 74 : 1255-62. [PMID : 28975240]

 

P.61 掲載の参考文献

3) Falcon B, Zhang W, Murzin AG, et al. Structures of filaments from Pick's disease reveal a novel tau protein fold. Nature. 2018 ; 561 : 137-40. [PMID : 30158706]

 

3) Peelaerts W, Bousset L, Van der Perren A, et al. α-Synuclein strains cause distinct synucleinopathies after local and systemic administration. Nature. 2015 ; 522 : 340-4. [PMID : 26061766]

 

5) Verma A. Prions, prion-like prionoids, and neurodegenerative disorders. Ann Indian Acad Neurol. 2016 ; 19 : 169-74. [PMID : 27293325]

 

6) Ridley RM, Baker HF, Windle CP, et al. Very long term studies of the seeding of beta-amyloidosis in primates. J Neural Transm (Vienna). 2006 ; 113 : 1243-51. [PMID : 16362635]

 

Meyer-Luehmann M, Coomaraswamy J, Bolmont T, et al. Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host. Science. 2006 ; 313 : 1781-4. [PMID : 16990547]

 

Clavaguera F, Akatsu H, Fraser G, et al. Brain homogenates from human tauopathies induce tau inclusions in mouse brain. Proc Natl Acad Sci U S A. 2013 ; 110 : 9535-40. [PMID : 23690619]

 

Prusiner SB, Woerman AL, Mordes DA, et al. Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism. Proc Natl Acad Sci U S A. 2015 ; 112 : E5308-17. [PMID : 26324905]

 

Porta S, Xu Y, Restrepo CR, et al. Patient-derived frontotemporal lobar degeneration brain extracts induce formation and spreading of TDP-43 pathology in vivo. Nat Commun. 2018 ; 9 : 4220. [PMID : 30310141]

 

P.62 掲載の参考文献

7) Jones DR, Delenclos M, Baine AT, et al. Transmission of Soluble and Insoluble α-Synuclein to Mice. J Neuropathol Exp Neurol. 2015 ; 74 : 1158-69. [PMID : 26574670]

 

8) Kim S, Kwon SH, Kam TI, et al. Transneuronal Propagation of Pathologic α-Synuclein from the Gut to the Brain Models Parkinson's Disease. Neuron. 2019 ; 103 : 627-41. e7. [PMID : 31255487]

 

9) Beach TG, Adler CH, Sue LI, et al. Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders. Acta Neuropathol. 2010 ; 119 : 689-702. [PMID : 20306269]

 

10) Rey NL, Wesson DW, Brundin P. The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases. Neurobiol Dis. 2018 ; 109 : 226-48. [PMID : 28011307]

 

11) Kordower JH, Freeman TB, Snow BJ, et al. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N Engl J Med. 1995 ; 332 : 1118-24. [PMID : 7700284]

 

Luk KC, Kehm V, Carroll J, et al. Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science. 2012 ; 338 : 949-53. [PMID : 23161999]

 

Olanow CW, Brundin P. Parkinson's disease and alpha synuclein : is Parkinson's disease a prion-like disorder? Mov Disord. 2013 ; 28 : 31-40. [PMID : 23390095]

 

Kordower JH, Chu Y, Hauser RA, et al. Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease. Nat Med. 2008 ; 14 : 504-6. [PMID : 18391962]

 

Li JY, Englund E, Holton JL, et al. Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation. Nat Med. 2008 ; 14 : 501-3. [PMID : 18391963]

 

P.63 掲載の参考文献

12) Jaunmuktane Z, Mead S, Ellis M, et al. Evidence for human transmission of amyloid-β pathology and cerebral amyloid angiopathy. Nature. 2015 ; 525 : 247-50. [PMID : 26354483]

 

13) Edgren G, Hjalgrim H, Rostgaard K, et al. Transmission of neurodegenerative disorders through blood transfusion : a cohort study. Ann Intern Med. 2016 ; 165 : 316-24. [PMID : 27368068]

 

Purro SA, Farrow MA, Linehan J, et al. Transmission of amyloid-β protein pathology from cadaveric pituitary growth hormone. Nature. 2018 ; 564 : 415-9. [PMID : 30546139]

 

Lyon J. study suggests Alzheimer and Parkinson disease are not transmitted through blood transfusion. JAMA. 2017 ; 317 : 123-4. [PMID : 28002556]

PubMed

各論2 頭痛

P.64 掲載の参考文献

1) The International Classification of Headache Disorders. 3rd edition https://www.ichd-3.org/ (2019年3月19日アクセス)

 

日本頭痛学会, 国際頭痛分類委員会, 訳. 国際頭痛分類 第3版. 東京 : 医学書院 ; 2018.

 

P.66 掲載の参考文献

3) Okumura T, Tanno S, Ohhira M, et al. Characteristics in patients with headache in an outpatient clinic in Japan. Asia Pac Fam Med. 2010 ; 9 : 10. [PMID : 21083939]

 

4) Goldstein JN, Camargo CA Jr, Pelletier AJ, et al. Headache in United States emergency departments : demographics, work-up and frequency of pathological diagnoses. Cephalalgia. 2006 ; 26 : 684-90. [PMID : 16686907]

 

5) Lewis DW, Qureshi F. Acute headache in children and adolescents presenting to the emergency department. Headache. 2000 ; 40 : 200-3. [PMID : 10759922]

 

Cvetkovic VV, Strineka M, Knezevic-Pavlic M, et al. Analysis of headache management in emergency room. Acta Clin Croat. 2013 ; 52 : 281-8. [PMID : 24558758]

 

Chu KH, Howell TE, Keijzers G, et al. Acute headache presentations to the emergency department : a statewide cross-sectional study. Acad Emerg Med 2017 ; 24 : 53-62. [PMID : 27473746]

 

P.68 掲載の参考文献

9) Ferrari MD, Klever RR, Terwindt GM, et al. Migraine pathophysiology : lessons from mouse models and human genetics. Lancet Neurol. 2015 ; 14 : 65-80. [PMID : 25496898]

 

10) Shah DR, Dilwali S, Friedman DI. Migraine aura without headache. Curr Pain Headache Rep. 2018 ; 22 : 77. [PMID : 30225597]

 

11) Blom JD. Alice in Wonderland syndrome : a systematic review. Neurol Clin Pract. 2016 ; 6 : 259-70. [PMID : 27347442]

 

P.69 掲載の参考文献

12) Detsky ME, McDonald DR, Baerlocher MO, et al. Does this patient with headache have a migraine or need neuroimaging? JAMA. 2006 ; 296 : 1274-83. [PMID : 16968852]

PubMed

13) Goadsby PJ, Wietecha LA, Dennehy EB, et al. Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine. Brain. 2019 ; 142 : 1894-904. [PMID : 31132795]

 

P.70 掲載の参考文献

15) Fumal A, Schoenen J. Tension-type headache : current research and clinical management. Lancet Neurol. 2008 ; 7 : 70-83. [PMID : 18093564]

 

16) Schwartz BS, Stewart WF, Simon D, et al. Epidemiology of tension-type headache. JAMA. 1998 ; 279 : 381-3. [PMID : 9459472]

 

P.72 掲載の参考文献

18) Bendtsen L, Evers S, Linde M, et al. EFNS guideline on the treatment of tension-type headache-report of an EFNS task force. Eur J Neurol. 2010 ; 17 : 1318-25. [PMID : 20482606]

 

19) Banzi R, Cusi C, Randazzo C, et al. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults. Cochrane Database Syst Rev. 2015 ; CD011681. [PMID : 25931277]

 

20) Fumal A, Schoenen J. Tension-type headache : current research and clinical management. Lancet Neurol. 2008 ; 7 : 70-83. [PMID : 18093564]

 

21) http://www.jhsnet.org/GUIDELINE/gl2013/189-213_3.pdf

 

22) Fogelholm R, Murros K. Tizanidine in chronic tension-type headache : a placebo controlled double-blind cross-over study. Headache.1992 ; 32 : 509-13. [PMID : 1468911]

 

P.73 掲載の参考文献

24) 岩田誠. 臨床医が語る しびれ, 頭痛から認知症まで神経内科のかかり方. 東京 : 日本評論社 ; 2013.

 

P.74 掲載の参考文献

26) Robbins MS, Starling AJ, Pringsheim TM, et al. Treatment of cluster headache : The American Headache Society Evidence-Based Guidelines. Headache. 2016 ; 56 : 1093-106. [PMID : 27432623]

 

27) 日本神経医学会, 日本頭痛学会, 監修. 慢性頭痛の診療ガイドライン 2013. http://www.jhsnet.org/GUIDELINE/gl2013/gl2013_main.pdf (2019年3月19日アクセス)

 

28) May A, Leone M, Afra J, et al. EFNS guidelines on the treatment of cluster headache and other trigeminal-autonomic cephalalgias. Eur J Neurol. 2006 ; 13 : 1066-77. [PMID : 16987158]

 

P.75 掲載の参考文献

29) Bennett MH, French C, Schnabel A, et al. Normobaric and hyperbaric oxygen therapy for the treatment and prevention of migraine and cluster headache. Cochrane Database Syst Rev. 2015 ; 12 : CD005219. [PMID : 26709672]

 

30) The Sumatriptan Cluster Headache Study Group. Treatment of acute cluster headache with sumatriptan. N Engl J Med. 1991 ; 325 : 322-6. [PMID : 1647496]

 

31) van Vliet JA, Bahra A, Martin V, et al. Intranasal sumatriptan in cluster headache : randomized placebo-controlled double-blind study. Neurology. 2003 ; 60 : 630-3. [PMID : 12601104]

 

32) May A, Leone M, Afra J, et al. EFNS guidelines on the treatment of cluster headache and other trigeminal-autonomic cephalalgias. Eur J Neurol. 2006 ; 13 : 1066-77. [PMID : 16987158]

 

33) May A, Leone M, Afra J, et al. EFNS guidelines on the treatment of cluster headache and other trigeminal-autonomic cephalalgias. Eur J Neurol. 2006 ; 13 : 1066-77. [PMID : 16987158]

 

日本神経医学会, 日本頭痛学会, 監修. 慢性頭痛の診療ガイドライン 2013. http://www.jhsnet.org/GUIDELINE/gl2013/gl2013_main.pdf

 

P.76 掲載の参考文献

34) Lambru G, Matharu MS. SUNCT and SUNA : medical and surgical treatments. Neurol Sci. 2013 ; 34 Suppl 1 : S75-81. [PMID : 23695051]

 

35) Alvarez R, Ramon C, Pascual J. Clues in the differential diagnosis of primary vs secondary cough, exercise, and sexual headaches. Headache. 2014 ; 54 : 1560-2. [PMID : 25298032]

 

P.77 掲載の参考文献

36) Maya Kaczorowski, Janusz Kaczorowski. Ice cream evoked headaches (ICE-H) study : randomised trial of accelerated versus cautious ice cream eating regimen. BMJ. 2002 ; 325 : 1445-46. [PMID : 12493658]

 

38) Lanteri-Minet M. Hypnic headache. Headache. 2014 ; 54 : 1556-9. [PMID : 25231430]

 

P.78 掲載の参考文献

39) Lynch KM, Brett F. Headaches that kill : a retrospective study of incidence, etiology and clinical features in cases of sudden death. Cephalalgia. 2012 ; 32 : 972-8. [PMID : 22875877]

 

P.80 掲載の参考文献

40) Lawton MT, Vates GE. Subarachnoid hemorrhage. N Engl J Med. 2017 ; 377 : 257-66. [PMID : 28723321]

 

P.81 掲載の参考文献

41) Dubosh NM, Bellolio MF, Rabinstein AA, et al. Sensitivity of early brain computed tomography to exclude aneurysmal subarachnoid hemorrhage : a systematic review and meta-analysis. Stroke. 2016 ; 47 : 750-5. [PMID : 26797666]

 

42) Perry JJ, Spacek A, Forbes M, et al. Is the combination of negative computed tomography result and negative lumbar puncture result sufficient to rule out subarachnoid hemorrhage? Ann Emerg Med. 2008 ; 51 : 707-13. [PMID : 18191293]

 

43) Edjlali M, Rodriguez-Regent C, Hodel J, et al. Subarachnoid hemorrhage in ten questions. Diagn Interv Imaging. 2015 ; 96 : 657-66. [PMID : 26141485]

 

P.82 掲載の参考文献

44) Heasley DC, Mohamed MA, Yousem DM. Clearing of red blood cells in lumbar puncture does not rule out ruptured aneurysm in patients with suspected subarachnoid hemorrhage but negative head CT findings. AJNR Am J Neuroradiol. 2005 ; 26 : 820-4. [PMID : 15814927]

PubMed

44) Perry JJ, Alyahya B, Sivilotti ML, et al. Differentiation between traumatic tap and aneurysmal subarachnoid hemorrhage : prospective cohort study. BMJ. 2015 ; 350 : h568. [PMID : 25694274]

 

45) Farzad A, Radin B, Oh JS, et al. Emergency diagnosis of subarachnoid hemorrhage : an evidence-based debate. J Emerg Med. 2013 ; 44 : 1045-53. [PMID : 23352866]

 

46) Westerlaan HE, van Dijk JM, Jansen-van der Weide MC, et al. Intracranial aneurysms in patients with subarachnoid hemorrhage : CT angiography as a primary examination tool for diagnosis--systematic review and meta-analysis. Radiology. 2011 ; 258 : 134-45. [PMID : 20935079]

 

P.84 掲載の参考文献

48) van de Beek D, de Gans J, Spanjaard L, et al. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med. 2004 ; 351 : 1849-59. [PMID : 15509818]

 

P.85 掲載の参考文献

49) Jacob JT, Mehta AK, Leonard MK. Acute forms of tuberculosis in adults. Am J Med. 2009 ; 122 : 12-7. [PMID : 19114163]

 

50) Rotbart HA. Viral meningitis. Seminars in Neurology 2000 ; 20 : 277-92. [PMID : 11051293]

 

51) McGill F, Griffiths MJ, Bonnett LJ, et al. Incidence, aetiology, and sequelae of viral meningitis in UK adults : a multicentre prospective observational cohort study. Lancet Infect Dis. 2018 ; 18 : 992-1003. [PMID : 30153934]

 

Yasar KK, Pehlivanoglu F, Sengoz G. Predictors of mortality in tuberculous meningitis : a multivariate analysis of 160 cases. Int J Tuberc Lung Dis. 2010 ; 14 : 1330-5. [PMID : 20843426]

 

Jongeling AC, Pisapia D. Pearls and oy-sters : tuberculous meningitis : not a diagnosis of exclusion. Neurology. 2013 ; 80 : e36-9. [PMID : 23339213]

PubMed

P.86 掲載の参考文献

52) Steiner I, Schmutzhard E, Sellner J, et al. EFNS-ENS guidelines for the use of PCR technology for the diagnosis of infections of the nervous system. Eur J Neurol. 2012 ; 19 : 1278-91. [PMID : 22882231]

 

P.89 掲載の参考文献

54) Masuhr F, Mehraein S, Einhaupl K. Cerebral venous and sinus thrombosis. J Neurol. 2004 ; 251 : 11-23. [PMID : 14999484]

 

55) Saposnik G, Barinagarrementeria F, Brown RD Jr, et al. Diagnosis and management of cerebral venous thrombosis : a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011 ; 42 : 1158-92. [PMID : 21293023]

 

56) Masuhr F, Mehraein S, Einhaupl K. Cerebral venous and sinus thrombosis. J Neurol. 2004 ; 251 : 11-23. [PMID : 14999484]

 

57) Saposnik G, Barinagarrementeria F, Brown RD Jr, et al. Diagnosis and management of cerebral venous thrombosis : a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011 ; 42 : 1158-92. [PMID : 21293023]

 

58) Crassard I, Soria C, Tzourio C. A negative D-dimer assay does not rule out cerebral venous thrombosis : a series of seventy-three patients. Stroke. 2005 ; 36 : 1716-9. [PMID : 16020765]

PubMed

59) Einhaupl K, Stam J, Bousser MG, et al. EFNS guideline on the treatment of cerebral venous and sinus thrombosis in adult patients. Eur J Neurol. 2010 ; 17 : 1229-35. [PMID : 20402748]

 

P.90 掲載の参考文献

60) Rajasekaran S, Vanderpump M, Baldeweg S, et al. UK guidelines for the management of pituitary apoplexy. Clin Endocrinol. 2011 ; 74 : 9-20. [PMID : 21044119]

 

61) Briet C, Salenave S, Bonneville JF, et al. Pituitary Apoplexy. Endocr Rev. 2015 ; 36 : 622-45. [PMID : 26414232]

 

P.91 掲載の参考文献

62) Cappelen-Smith C, Calic Z, Cordato D. Reversible cerebral vasoconstriction syndrome : recognition and treatment. Curr Treat Options Neurol. 2017 ; 19 : 21. [PMID : 28456915]

 

63) Boddhula SK, Boddhula S, Gunasekaran K, et al. An unusual cause of thunderclap headache after eating the hottest pepper in the world- "The Carolina Reaper". BMJ Case Rep. 2018 Apr 9. [PMID : 29632122]

 

63) Ducros A, Wolff V. The Typical thunderclap headache of reversible cerebral vasoconstriction syndrome and its various triggers. Headache. 2016 ; 56 : 657-73. [PMID : 27015869]

 

65) Ducros A, Wolff V. The typical thunderclap headache of reversible cerebral vasoconstriction syndrome and its various triggers. Headache. 2016 ; 56 : 657-73. [PMID : 27015869]

 

66) Lee MJ, Cha J, Choi HA. Blood-brain barrier breakdown in reversible cerebral vasoconstriction syndrome : Implications for pathophysiology and diagnosis. Ann Neurol. 2017 ; 81 : 454-66. [PMID : 28195428]

 

P.92 掲載の参考文献

67) Singhal AB, Topcuoglu MA. Glucocorticoid-associated worsening in reversible cerebral vasoconstriction syndrome. Neurology. 2017 ; 88 : 228-236. [PMID : 27940651]

 

P.93 掲載の参考文献

68) Fugate JE, Rabinstein AA. Posterior reversible encephalopathy syndrome : clinical and radiological manifestations, pathophysiology, and outstanding questions. Lancet Neurol. 2015 ; 14 : 914-25. [PMID : 26184985]

 

69) Teale EA, Iliffe S, Young JB. Subdural haematoma in the elderly. BMJ. 2014 ; 348 : g1682. [PMID : 24620354]

 

70) Kolias AG, Chari A, Santarius T, et al. Chronic subdural haematoma : modern management and emerging therapies. Nat Rev Neurol. 2014 ; 10 : 570-8. [PMID : 25224156]

 

71) 陶山一彦, 林健太郎, 永田泉. 脳動脈解離. Brain Nerve. 2008 ; 60 : 1115-23.

 

P.94 掲載の参考文献

72) Flis CM, Jager HR, Sidhu PS. Carotid and vertebral artery dissections : clinical aspects, imaging features and endovascular treatment. Eur Radiol. 2007 ; 17 : 820-34. [PMID : 16871383]

 

73) Silbert PL, Mokri B, Schievink WI. Headache and neck pain in spontaneous internal carotid and vertebral artery dissections. Neurology. 1995 ; 45 : 1517-22. [PMID : 7644051]

 

74) Fatima Z, Motosugi U, Okumura A. Basi-parallel anatomical scanning (BPAS) -MRI can improve discrimination of vertebral artery dissection from atherosclerosis and hypoplasia. Acad Radiol. 2012 ; 19 : 1362-7. [PMID : 22906594]

 

75) Hosoya T, Watanabe N, Yamaguchi K, et al. Intracranial vertebral artery dissection in Wallenberg syndrome. AJNR Am J Neuroradiol. 1994 ; 15 : 1161-5. [PMID : 8073988]

 

P.95 掲載の参考文献

76) Nagel MA, White T, Khmeleva N, et al. Analysis of varicella-zoster virus in temporal arteries biopsy positive and negative for giant cell arteritis. JAMA Neurol. 2015 ; 72 : 1281-7. [PMID : 26349037]

 

77) Kuo CH, McCluskey P, Fraser CL. Chewing gum test for jaw claudication in giant-cell arteritis. N Engl J Med. 2016 ; 374 : 1794-5. [PMID : 27144869]

 

78) Nesher G, Breuer GS. Giant cell arteritis and polymyalgia rheumatica : 2016 update. Rambam Maimonides Med J. 2016 ; 7. [PMID : 27824543]

 

Gilden D, White T, Boyer PJ, et al. Varicella zoster virus infection in granulomatous arteritis of the aorta. J Infect Dis. 2016 ; 213 : 1866-71. [PMID : 27037084]

 

Solomon IH, Docken WP, Padera RF. Giant cell arteritis is not associated with varicella zoster virus in temporal artery biopsies or ascending aortic resections. J Rheumatol. 2019. [Epub ahead of print] [PMID : 30824633]

 

P.97 掲載の参考文献

79) Gonzalez-Gay MA, Matteson EL, Castaneda S. Polymyalgia rheumatica. Lancet. 2017 ; 390 : 1700-12. [PMID : 28774422]

 

80) Kermani TA, Schmidt J, Crowson CS, et al. Utility of erythrocyte sedimentation rate and C-reactive protein for the diagnosis of giant cell arteritis. Semin Arthritis Rheum. 2012 ; 41 : 866-71. [PMID : 22119103]

 

81) Duftner C, Dejaco C, Sepriano A, et al. Imaging in diagnosis, outcome prediction and monitoring of large vessel vasculitis : a systematic literature review and meta-analysis informing the EULAR recommendations. RMD Open. 2018 ; 4 : e000612. [PMID : 29531788]

 

P.98 掲載の参考文献

82) Luqmani R, Lee E, Singh S, et al. The Role of Ultrasound Compared to Biopsy of Temporal Arteries in the Diagnosis and Treatment of Giant Cell Arteritis (TABUL) : a diagnostic accuracy and cost-effectiveness study. Health Technol Assess. 2016 ; 20 : 1-238. [PMID : 27925577]

 

83) Narvaez J, Bernad B, Roig-Vilaseca D, et al. Influence of previous corticosteroid therapy on temporal artery biopsy yield in giant cell arteritis. Semin Arthritis Rheum. 2007 ; 37 : 13-9. [PMID : 17360027]

 

84) Kennedy PG. Zoster sine herpete : it would be rash to ignore it. Neurology. 2011 ; 76 : 416-7. [PMID : 21282588]

 

85) Dougherty C. Occipital neuralgia. Curr Pain Headache Rep. 2014 ; 18 : 411. [PMID : 24737457]

 

Breuer GS, Nesher R, Nesher G. Effect of biopsy length on the rate of positive temporal artery biopsies. Clin Exp Rheumatol. 2009 ; 27 (1 Suppl 52) : S10-3. [PMID : 19646339]

 

P.101 掲載の参考文献

86) Ducros A, Bousser MG. Thunderclap headache. BMJ. 2013 ; 346 : e8557. [PMID : 23303883]

 

P.102 掲載の参考文献

87) Devenney E, Neale H, Forbes RB. A systematic review of causes of sudden and severe headache (Thunderclap Headache) : should lists be evidence based? J Headache Pain. 2014 ; 15 : 49. [PMID : 25123846]

 

88) Mokri B. Spontaneous low pressure, low CSF volume headaches : spontaneous CSF leaks. Headache. 2013 ; 53 : 1034-53. [PMID : 23808630]

 

91) Straus SE, Thorpe KE, Holroyd-Leduc J. How do I perform a lumbar puncture and analyze the results to diagnose bacterial meningitis? JAMA. 2006 ; 296 : 2012-22. [PMID : 17062865]

 

P.103 掲載の参考文献

92) Arevalo-Rodriguez I, Ciapponi A, Roque i Figuls M, et al. Posture and fluids for preventing post-dural puncture headache. Cochrane Database Syst Rev. 2016 ; 3 : CD009199. [PMID : 26950232]

 

93) Rochwerg B, Almenawer SA, Siemieniuk RAC, et al. Atraumatic (pencil-point) versus conventional needles for lumbar puncture : a clinical practice guideline. BMJ. 2018 ; 361 : k1920. [PMID : 29789372]

 

Nath S, Koziarz A, Badhiwala JH, et al. Atraumatic versus conventional lumbar puncture needles : a systematic review and meta-analysis. Lancet. 2018 ; 391 : 1197-204. [PMID : 29223694]

 

Rochwerg, Almenawer SA, Siemieniuk RAC, et al. Atraumatic (pencil-point) versus conventional needles for lumbar puncture : a clinical practice guideline. BMJ. 2018 ; 361 : k1920. [PMID : 29789372]

 

P.104 掲載の参考文献

94) Schievink WI. Spontaneous spinal cerebrospinal fluid leaks and intracranial hypotension. JAMA. 2006 ; 295 : 2286-96. [PMID : 16705110]

 

P.105 掲載の参考文献

95) Lewis J, Fourman S. Subacute angle-closure glaucoma as a cause of headache in the presence of a white eye. Headache. 1998 ; 38 : 684-6. [PMID : 15613181]

 

P.106 掲載の参考文献

97) https://www.independent.co.uk/life-style/health-and-families/viagra-buy-without-prescription-over-counter-uk-pharmacies-male-impotence-erectile-dysfunction-a8275461.html

 

P.107 掲載の参考文献

99) 井口正寛. 髄膜炎の歴史とその診察法の歴史. In : Annual Review神経 2018. 東京 : 中外医学社 ; 2018. 136-47.

 

P.108 掲載の参考文献

101) Iguchi M, Noguchi Y, Yamamoto S, et al. Diagnostic test accuracy of jolt accentuation for headache in acute meningitis in the emergency setting. Cochrane Database of Systematic Reviews 2017, Issue 10. Art. No. : CD012824. DOI : 10.1002/14651858.CD012824 (in press)

 

P.109 掲載の参考文献

102) Don't do imaging for uncomplicated headache. http://www.choosingwisely.org/clinician-lists/american-college-radiology-imaging-for-uncomplicated-headache/

 

103) Gibson LM, Paul L, Chappell FM, et al. Potentially serious incidental findings on brain and body magnetic resonance imaging of apparently asymptomatic adults : systematic review and meta-analysis. BMJ. 2018 ; 363 : k4577. [PMID : 30467245]

 

P.110 掲載の参考文献

105) Don't perform neuroimaging studies in patients with stable headaches that meet criteria for migraine. http://www.choosingwisely.org/clinician-lists/american-headache-society-neuroimaging-for-stable-headaches/

 

106) Don't perform computed tomography (CT) imaging for headache when magnetic resonance imaging (MRI) is available, except in emergency settings. http://www.choosingwisely.org/clinician-lists/american-headache-society-ct-imaging-for-headache/

 

P.111 掲載の参考文献

107) 水澤英洋, 監修. 太田浄文, 石原正一郎, 著. 髄液検査データブック. 新興医学出版社

 

108) Hase R, Hosokawa N, Yaegashi M, et al. Bacterial meningitis in the absence of cerebrospinal fluid pleocytosis : a case report and review of the literature. Can J Infect Dis Med Microbiol. 2014 ; 25 : 249-51. [PMID : 25371685]

 

108) Thwaites GE, Tran TH. Tuberculous meningitis : many questions, too few answers. Lancet Neurol. 2005 ; 4 : 160-70. [PMID : 15721826]

 

109) Singh AK, Malhotra HS, Garg RK, et al. Paradoxical reaction in tuberculous meningitis : presentation, predictors and impact on prognosis. BMC Infect Dis. 2016 ; 16 : 306. [PMID : 27329253]

 

P.112 掲載の参考文献

110) Rice SK, Heinl RE, Thornton LL, et al. Clinical characteristics, management strategies, and cost implications of a statewide outbreak of enterovirus meningitis. Clin Infect Dis. 1995 ; 20 : 931-7. [PMID : 7795097]

 

111) Fitch MT, van de Beek D. Emergency diagnosis and treatment of adult meningitis. Lancet Infect Dis. 2007 ; 7 : 191-200. [PMID : 17317600]

 

112) van de Beek D, de Gans J, Spanjaard L, et al. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med. 2004 ; 351 : 1849-59. [PMID : 15509818]

 

113) Chin JH. Tuberculous meningitis : Diagnostic and therapeutic challenges. Neurol Clin Pract. 2014 ; 4 : 199-205. [PMID : 25110618]

 

114) Thwaites GE, Chau TT, Farrar JJ. Improving the bacteriological diagnosis of tuberculous meningitis. J Clin Microbiol. 2004 ; 42 : 378-9. [PMID : 14715783]

 

P.113 掲載の参考文献

115) Pai M, Flores LL, Pai N, et al. Diagnostic accuracy of nucleic acid amplification tests for tuberculous meningitis : a systematic review and meta-analysis. Lancet Infect Dis. 2003 ; 3 : 633-43. [PMID : 14522262]

 

116) Pormohammad A, Riahi SM, Nasiri MJ, et al. Diagnostic test accuracy of adenosine deaminase for tuberculous meningitis : a systematic review and meta-analysis. J Infect. 2017 ; 74 : 545-54. [PMID : 28366687]

 

P.114 掲載の参考文献

117) Ball AK, Clarke CE. Idiopathic intracranial hypertension. Lancet Neurol. 2006 ; 5 : 433-42. [PMID : 16632314]

 

P.116 掲載の参考文献

1) Ferrari MD, Roon KI, Lipton RB, et al. Oral triptans (serotonin 5-HT (1B/1D) agonists) in acute migraine treatment : a meta-analysis of 53 trials. Lancet. 2001 ; 358 : 1668-75. [PMID : 11728541]

 

2) Loder E. Triptan therapy in migraine. N Engl J Med. 2010 ; 363 : 63-70. [PMID : 20592298]

 

P.118 掲載の参考文献

3) Evers S, Afra J, Frese A, et al. EFNS guideline on the drug treatment of migraine-revised report of an EFNS task force. Eur J Neurol. 2009 ; 16 : 968-81. [PMID : 19708964]

 

4) Orlova Y, Rizzoli P, Loder E. Association of coprescription of triptan antimigraine drugs and selective serotonin reuptake inhibitor or selective norepinephrine reuptake inhibitor antidepressants with serotonin syndrome. JAMA Neurol. 2018 ; 75 : 566-72. [PMID : 29482205]

PubMed

P.119 掲載の参考文献

5) Spielmann K, Kayser A, Beck E, et al. Pregnancy outcome after anti-migraine triptan use : a prospective observational cohort study. Cephalalgia. 2018 ; 38 : 1081-92. [PMID : 28758416]

 

6) Duong S, Bozzo P, Nordeng H, et al. Safety of triptans for migraine headaches during pregnancy and breastfeeding. Can Fam Physician. 2010 ; 56 : 537-9. [PMID : 20547518]

 

7) https://www.ncchd.go.jp/kusuri/lactation/druglist_yakkou.html

 

P.120 掲載の参考文献

3) Vollesen ALH, Snoer A, Beske RP, et al. Effect of Infusion of Calcitonin Gene-Related Peptide on Cluster Headache Attacks : A Randomized Clinical Trial. JAMA Neurol. 2018 ; 75 : 1187-97. [PMID : 29987329]

 

4) https://www.tevapharm.com/news/teva_announces_update_on_fremanezumab_clinical_development_for_use_in_episodic_cluster_headache_04_19.aspx

 

各論3 けいれん

P.131 掲載の参考文献

3) Fisher RS, van Emde Boas W, Blume W, et al. Epileptic seizures and epilepsy : definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia. 2005 ; 46 : 470-2. [PMID : 15816939]

 

P.132 掲載の参考文献

4) Fisher RS, Acevedo C, Arzimanoglou A, et al. ILAE official report : a practical clinical definition of epilepsy. Epilepsia. 2014 ; 55 : 475-82. [PMID : 24730690] (邦訳 : てんかんの実用的臨床定義 http://square.umin.ac.jp/jes/images/jes-image/Definition2014-Jpn.pdf)

 

P.133 掲載の参考文献

6) Krumholz A, Wiebe S, Gronseth GS, et al. Evidence-based guideline : Management of an unprovoked first seizure in adults : Report of the Guideline Development Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2015 ; 84 : 1705-13. [PMID : 25901057]

 

9) Hesdorffer DC, Benn EK, Cascino GD, et al. Is a first acute symptomatic seizure epilepsy? Mortality and risk for recurrent seizure. Epilepsia. 2009 ; 50 : 1102-8. [PMID : 19374657]

 

10) Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia. 1981 ; 22 : 489-501. [PMID : 6790275]

 

11) Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia. 1989 ; 30 : 389-99. [PMID : 2502382]

 

P.134 掲載の参考文献

12) Berg AT, Berkovic SF, Brodie MJ, et al. Revised terminology and concepts for organization of seizures and epilepsies : report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia. 2010 ; 51 : 676-85. [PMID : 20196795]

 

P.136 掲載の参考文献

16) Strozzi I, Nolan SJ, Sperling MR, et al. Early versus late antiepileptic drug withdrawal for people with epilepsy in remission. Cochrane Database Syst Rev. 2015 ; 2 : CD001902. [PMID : 25922863]

 

P.137 掲載の参考文献

17) Specchio LM, Beghi E. Should antiepileptic drugs be withdrawn in seizure-free patients? CNS Drugs. 2004 ; 18 : 201-12. [PMID : 15015901]

 

18) Chen Z, Brodie MJ, Liew D, et al. Treatment Outcomes in Patients With Newly Diagnosed Epilepsy Treated With Established and New Antiepileptic Drugs : A 30-Year Longitudinal Cohort Study. JAMA Neurol. 2018 ; 75 : 279-86. [PMID : 29279892]

 

P.139 掲載の参考文献

20) Israni RK, Kasbekar N, Haynes K, et al. Use of antiepileptic drugs in patients with kidney disease. Semin Dial. 2006 ; 19 : 408-16. [PMID : 16970741]

 

23) Shi YW, Min FL, Zhou D, et al. HLA-A*24 : 02 as a common risk factor for antiepileptic drug-induced cutaneous adverse reactions. Neurology. 2017 ; 88 : 2183-91. [PMID : 28476759]

 

厚生労働省. カルバマゼピンによる重症薬疹と遺伝子多型について. https://www.mhlw.go.jp/www1/kinkyu/iyaku_j/iyaku_j/anzenseijyouhou/285-2.pdf

 

Mushiroda T, Takahashi Y, Onuma T, et al. Association of HLA-A*31 : 01 screening with the incidence of carbamazepine-induced cutaneous adverse reactions in a Japanese population. JAMA Neurol. 2018 ; 75 : 842-9. [PMID : 29610831]

 

P.140 掲載の参考文献

25) Phillips EJ, Sukasem C, Whirl-Carrillo M, et al. Clinical pharmacogenetics implementation consortium guideline for HLA genotype and use of carbamazepine and oxcarbazepine : 2017 update. Clin Pharmacol Ther. 2018 ; 103 : 574-81. [PMID : 29392710]

 

27) Tateno A, Sawada K, Takahashi I, et al. Carbamazepine-induced transient auditory pitch-perception deficit. Pediatr Neurol. 2006 ; 35 : 131-4. [PMID : 16876011]

 

28) Israni RK, Kasbekar N, Haynes K, et al. Use of antiepileptic drugs in patients with kidney disease. Semin Dial. 2006 ; 19 : 408-16. [PMID : 16970741]

 

Gur-Ozmen S, Nirmalananthan N, von Oertzen TJ. Change of pitch due to carbamazepine and oxcarbazepine independently. Seizure. 2013 ; 22 : 162-3. [PMID : 23266347]

 

Kobayashi T, Nisijima K, Ehara Y, et al. Pitch perception shift : a rare side-effect of carbamazepine. Psychiatry Clin Neurosci. 2001 ; 55 : 415-7. [PMID : 11442894]

 

副作用モニター情報 <364> フラベリック錠 : 音が半音下がって聞こえる副作用について. https://www.min-iren.gr.jp/?p=15659

 

P.141 掲載の参考文献

29) Chen Z, Lusicic A, O'Brien TJ, et al. Psychotic disorders induced by antiepileptic drugs in people with epilepsy. Brain. 2016 ; 139 : 2668-78. [PMID : 27503872]

 

30) Josephson CB, Engbers JDT, Jette N, et al. Prediction tools for psychiatric adverse effects after levetiracetam prescription. JAMA Neurol. 2019 ; 76 : 440-6. [PMID : 30688969]

 

31) Bhoi SK, Kalita J, Misra UK. Skin rash following levetiracetam. Seizure. 2016 ; 37 : 45-7. [PMID : 26987035]

 

P.142 掲載の参考文献

32) Israni RK, Kasbekar N, Haynes K, et al. Use of antiepileptic drugs in patients with kidney disease. Semin Dial. 2006 ; 19 : 408-16. [PMID : 16970741]

 

34) Kanner AM. Lamotrigine-induced rash : Can we stop worrying? Epilepsy Curr. 2005 ; 5 : 190-1. [PMID : 16175221]

 

36) Schmidt D, Schachter SC. Drug treatment of epilepsy in adults. BMJ. 2014 ; 348 : g254. [PMID : 24583319]

 

P.143 掲載の参考文献

38) Bourgeois BF. Broader is better : the ranks of broad-spectrum antiepileptic drugs are growing. Neurology. 2007 ; 69 : 1734-6. [PMID : 17967991]

 

P.144 掲載の参考文献

39) Israni RK, Kasbekar N, Haynes K, et al. Use of antiepileptic drugs in patients with kidney disease. Semin Dial. 2006 ; 19 : 408-16. [PMID : 16970741]

 

40) Walker V. Ammonia metabolism and hyperammonemic disorders. Adv Clin Chem. 2014 ; 67 : 73-150. [PMID : 25735860]

 

41) Chicharro AV, de Marinis AJ, Kanner AM. The measurement of ammonia blood levels in patients taking valproic acid : looking for problems where they do not exist? Epilepsy Behav. 2007 ; 11 : 361-6. [PMID : 17845866]

PubMed

42) Chicharro AV, de Marinis AJ, Kanner AM. The measurement of ammonia blood levels in patients taking valproic acid : looking for problems where they do not exist? Epilepsy Behav. 2007 ; 11 : 361-6. [PMID : 17845866]

PubMed

Wadzinski J, Franks R, Roane D, et al. Valproate-associated hyperammonemic encephalopathy. J Am Board Fam Med. 2007 ; 20 : 499-502. [PMID : 17823470]

 

P.145 掲載の参考文献

43) Baddour E, Tewksbury A, Stauner N. Valproic acid-induced hyperammonemia : Incidence, clinical significance, and treatment management. Ment Health Clin. 2018 ; 8 : 73-7. [PMID : 29955549]

 

45) Fried S, Kozer E, Nulman, et al. Malformation rates in children of women with untreated epilepsy : a meta-analysis. Drug Saf. 2004 ; 27 : 197-202. [PMID : 14756581]

 

46) Weston J, Bromley R, Jackson CF, et al. Monotherapy treatment of epilepsy in pregnancy : congenital malformation outcomes in the child. Cochrane Database Syst Rev. 2016 ; 11 : CD010224. [PMID : 27819746]

 

47) Bromley R, Weston J, Adab N, Treatment for epilepsy in pregnancy : neurodevelopmental outcomes in the child. Cochrane Database Syst Rev. 2014 ; 10 : CD010236. [PMID : 25354543]

 

Walker V. Ammonia metabolism and hyperammonemic disorders. Adv Clin Chem. 2014 ; 67 : 73-150. [PMID : 25735860]

 

P.146 掲載の参考文献

48) Harden CL, Meador KJ, Pennell PB, et al. Practice parameter update : management issues for women with epilepsy-focus on pregnancy (an evidence-based review) : teratogenesis and perinatal outcomes : report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology. 2009 ; 73 : 133-41. [PMID : 19398681]

 

49) Harden CL, Hopp J, Ting TY, et al. Practice parameter update : management issues for women with epilepsy-focus on pregnancy (an evidence-based review) : obstetrical complications and change in seizure frequency : report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology. 2009 ; 73 : 126-32. [PMID : 19398682]

 

Hernandez-Diaz S, Smith CR, Shen A, et al. Comparative safety of antiepileptic drugs during pregnancy. Neurology. 2012 ; 78 : 1692-9 [PMID : 22551726]

 

Hernandez-Diaz S, Huybrechts KF, Desai RJ, et al. Topiramate use early in pregnancy and the risk of oral clefts : a pregnancy cohort study. Neurology. 2018 ; 90 : e342-e351. [PMID : 29282333]

 

P.147 掲載の参考文献

50) 日本神経学会, 監修. てんかん診療ガイドライン 2018. 東京 : 医学書院.

 

51) Harden CL, Pennell PB, Koppel BS, et al. Practice parameter update : management issues for women with epilepsy-focus on pregnancy (an evidence-based review) : vitamin K, folic acid, blood levels, and breastfeeding : report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology. 2009 ; 73 : 142-9. [PMID : 19398680]

 

52) NICE Clinical guideline [CG137] . Epilepsies : diagnosis and management. 2012. https://www.nice.org.uk/guidance/cg137

 

53) Scottish Intercollegiate Guidelines Network (SIGN). Diagnosis and management of epilepsy in adults. Edinburgh : SIGN ; 2015. http://www.sign.ac.uk/assets/sign143.pdf

 

54) Peljto AL, Barker-Cummings C, Vasoli VM, et al. Familial risk of epilepsy : a population-based study. Brain. 2014 ; 137 : 795-805. [PMID : 24468822]

 

P.149 掲載の参考文献

57) Trinka E, Cock H, Hesdorffer D, et al. A definition and classification of status epilepticus-Report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia. 2015 ; 56 : 1515-23. [PMID : 26336950]

 

P.151 掲載の参考文献

58) Kapur J, Elm J, Chamberlain JM, et al. Randomized trial of three anticonvulsant medications for status epilepticus. N Engl J Med. 2019 ; 381 : 2103-13. [PMID : 31774955]

 

59) Betjemann JP, Lowenstein DH. Status epilepticus in adults. Lancet Neurol. 2015 ; 14 : 615-24. [PMID : 25908090]

 

60) Kam PC, Cardone D. Propofol infusion syndrome. Anaesthesia. 2007 ; 62 : 690-701. [PMID : 17567345]

 

P.152 掲載の参考文献

61) Kalilani L, Sun X, Pelgrims B, et al. The epidemiology of drug-resistant epilepsy : a systematic review and meta-analysis. Epilepsia. 2018 ; 59 : 2179-93. [PMID : 30426482]

 

62) Schmidt D, Schachter SC. Drug treatment of epilepsy in adults. BMJ. 2014 ; 348 : g254. [PMID : 24583319]

 

P.155 掲載の参考文献

63) Hesdorffer DC, Benn EK, Cascino GD, et al. Is a first acute symptomatic seizure epilepsy? Mortality and risk for recurrent seizure. Epilepsia. 2009 ; 50 : 1102-8. [PMID : 19374657]

 

P.157 掲載の参考文献

64) Hesdorffer DC, Logroscino G, Cascino G, et al. Risk of unprovoked seizure after acute symptomatic seizure : effect of status epilepticus. Ann Neurol. 1998 ; 44 : 908-12. [PMID : 9851435]

 

P.158 掲載の参考文献

66) 循環器病の診断と治療に関するガイドライン (2011年度合同研究班報告). 失神の診断・治療ガイドライン (2012年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2012_inoue_h.pdf

 

67) Task Force for the Diagnosis and Management of Syncope ; European Society of Cardiology (ESC) ; European Heart Rhythm Association (EHRA) ; et al. Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J. 2009 ; 30 : 2631-71. [PMID : 19713422]

 

Shen WK, Sheldon RS, Benditt DG, et al. 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope : A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2017 ; 136 : e60-e122. [PMID : 28280231)

 

循環器病の診断と治療に関するガイドライン (2011年度合同研究班報告). 失神の診断・治療ガイドライン (2012年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2012_inoue_h.pdf

 

P.159 掲載の参考文献

68) Prandoni P, Lensing AW, Prins MH, et al. Prevalence of pulmonary embolism among patients hospitalized for syncope. N Engl J Med. 2016 ; 375 : 1524-31. [PMID : 27797317]

 

Costantino G, Ruwald MH, Quinn J, et al. Prevalence of pulmonary embolism in patients with syncope. JAMA Intern Med. 2018 ; 178 : 356-62. [PMID : 29379959]

 

Oqab Z, Ganshorn H, Sheldon R. Prevalence of pulmonary embolism in patients presenting with syncope. A systematic review and meta-analysis. Am J Emerg Med. 2018 ; 36 : 551-5. [PMID : 28947223]

 

P.160 掲載の参考文献

70) LaFrance WC. Psychogenic non-epileptic seizures. In : Hallett M, et al. Editors. Psychogenic movement disorders and other conversion disorders. Cambridge : Cambridge university press ; 2011. p.71-82.

 

71) Lesser RP. Treatment and outcome of psychogenic nonepileptic seizures. In : Hallett M, et al. Editors. Psychogenic movement disorders. Philadelphia : Lippincott Williams & Wilkins ; 2006. p.82-7.

 

P.161 掲載の参考文献

73) Saygi S, Katz A, Marks DA, et al. Frontal lobe partial seizures and psychogenic seizures : comparison of clinical and ictal characteristics. Neurology. 1992 ; 42 : 1274-7. [PMID : 1620332]

 

P.165 掲載の参考文献

78) Bhattacharyya S, Darby RR, Raibagkar P, et al. Antibiotic-associated encephalopathy. Neurology. 2016 ; 86 : 963-71. [PMID : 26888997]

 

P.168 掲載の参考文献

80) Hung TY, Chen CC, Wang TL, et al. Transient hyperammonemia in seizures : a prospective study. Epilepsia. 2011 ; 52 : 2043-9. [PMID : 21972984]

 

81) Chen DK, So YT, Fisher RS ; Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Use of serum prolactin in diagnosing epileptic seizures : report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2005 ; 65 : 668-75. [PMID : 16157897]

 

82) Nass RD, Sassen R, Elger CE, et al. The role of postictal laboratory blood analyses in the diagnosis and prognosis of seizures. Seizure. 2017 ; 47 : 51-65. [PMID : 28288363]

 

P.169 掲載の参考文献

83) Gilbert DL, Sethuraman G, Kotagal U, et al. Meta-analysis of EEG test performance shows wide variation among studies. Neurology. 2003 ; 60 : 564-70. [PMID : 12601093]

 

P.172 掲載の参考文献

1) Dalmau J, Tuzun E, Wu HY, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol. 2007 ; 61 : 25-36. [PMID : 17262855]

 

4) Dalmau J, Lancaster E, Martinez-Hernandez E, et al. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 2011 ; 10 : 63-74. [PMID : 21163445]

 

P.173 掲載の参考文献

5) Dalmau J, Lancaster E, Martinez-Hernandez E, et al. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 2011 ; 10 : 63-74. [PMID : 21163445]

 

6) Pruss H, Finke C, Holtje M, et al. N-methyl-D-aspartate receptor antibodies in herpes simplex encephalitis. Ann Neurol. 2012 ; 72 : 902-11. [PMID : 23280840]

 

Kumpfel T, Gerdes LA, Heck C, et al. Delayed diagnosis of extraovarian teratoma in relapsing anti-NMDA receptor encephalitis. Neurol Neuroimmunol Neuroinflamm. 2016 ; 3 : e250. [PMID : 27354987]

 

P.175 掲載の参考文献

7) Kaneko A, Kaneko J, Tominaga N, et al. Pitfalls in clinical diagnosis of anti-NMDA receptor encephalitis. J Neurol. 2018 ; 26 : 586-96. [PMID : 29356973]

 

8) Dalmau J, Lancaster E, Martinez-Hernandez E, et al. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 2011 ; 10 : 63-74. [PMID : 21163445]

 

9) Behrendt V, Krogias C, Reinacher-Schick A, et al. Bortezomib treatment for patients with anti-N-methyl-D-aspartate receptor encephalitis. JAMA Neurol. 2016 ; 73 : 1251-3. [PMID : 27533122]

 

9) Scheibe F, Pruss H, Mengel AM, et al. Bortezomib for treatment of therapy-refractory anti-NMDA receptor encephalitis. Neurology. 2017 ; 88 : 366-70. [PMID : 28003505]

 

10) Buckley C, Oger J, Clover L, et al. Potassium channel antibodies in two patients with reversible limbic encephalitis. Ann Neurol. 2001 ; 50 : 73-8. [PMID : 11456313]

 

11) Irani SR, Alexander S, Waters P, et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia. Brain. 2010 ; 133 : 2734-48. [PMID : 20663977]

 

Lai M, Huijbers MG, Lancaster E, et al. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels : a case series. Lancet Neurol. 2010 ; 9 : 776-85. [PMID : 20580615]

 

P.181 掲載の参考文献

4) Mezaki T. George Gershwin's death and Duret haemorrhage. Lancet. 2017 ; 390 : 646. [PMID : 28816130]

 

5) Sloop GD. What caused George Gershwin's untimely death? J Med Biogr. 2001 ; 9 : 28-30. [PMID : 11177784]

 

ヤング・ピープルズ・コンサート Vol. 1/レナード・バーンスタイン (Young People's Concert Vol I/Leonard Bernstein) [DVD] より「アメリカ音楽とは?」

 

岩田誠. 脳と音楽. 東京 : メディカルレビュー社 ; 2001.

 

ジョン・オシエー. 菅野弘久, 訳. 音楽と病 病歴にみる大作曲家の姿. 東京 : 法政大学出版局 ; 1996.

 

Kasdan ML. The final days of George Gershwin, American composer. September 26, 1898-July 11, 1937. 50th anniversary. J Ky Med Assoc. 1987 ; 85 : 649-52. [PMID : 3320234]

 

各論4 震え

P.182 掲載の参考文献

1) Bhatia KP, Bain P, Bajaj N, et al. Consensus Statement on the classification of tremors. from the task force on tremor of the International Parkinson and Movement Disorder Society. Mov Disord. 2018 ; 33 : 75-87. [29193359]

PubMed

P.183 掲載の参考文献

2) Louis ED. Clinical practice. Essential tremor. N Engl J Med. 2001 ; 345 : 887-91. [PMID : 11565522]

 

P.184 掲載の参考文献

3) Deuschl G, Bain P, Brin M. Consensus statement of the Movement Disorder Society on Tremor. Ad Hoc Scientific Committee. Mov Disord. 1998 ; 13 Suppl 3 : 2-23. [PMID : 9827589]

 

4) Bhatia KP, Bain P, Bajaj N, et al. Consensus Statement on the classification of tremors. from the task force on tremor of the International Parkinson and Movement Disorder Society. Mov Disord. 2018 ; 33 : 75-87. [PMID : 29193359]

 

P.186 掲載の参考文献

7) http://www.nichiyaku.or.jp/kokumin.php

PubMed

8) Hagglund JV. Hitler's parkinson's disease : a videotape illustration. Mov Disord. 1992 ; 7 : 383-4. [PMID : 1484538]

 

9) Jankovic J, Schwartz KS, Ondo W. Re-emergent tremor of Parkinson's disease. J Neurol Neurosurg Psychiatry. 1999 ; 67 : 646-50. [PMID : 10519872]

 

Gupta R, Kim C, Agarwal N, et al. Understanding the Influence of Parkinson disease on Adolf Hitler's decision-making during World War II. World Neurosurg. 2015 ; 84 : 1447-52. [PMID : 26093359]

 

P.188 掲載の参考文献

11) Mittal S, Bjornevik K, Im DS, et al. β2-Adrenoreceptor is a regulator of the α-synuclein gene driving risk of Parkinson's disease. Science. 2017 ; 357 : 891-8. [PMID : 28860381]

 

P.189 掲載の参考文献

14) Koller WC, Vetere-Overfield B. Acute and chronic effects of propranolol and primidone in essential tremor. Neurology. 1989 ; 39 : 1587-8. [PMID : 2586774]

 

15) Elias WJ, Lipsman N, Ondo WG, et al. A randomized trial of focused ultrasound thalamotomy for essential tremor. N Engl J Med. 2016 ; 375 : 730-9. [PMID : 27557301]

 

P.190 掲載の参考文献

17) 萬年甫, 訳編. 神経学の源流 1 ババンスキーとともに-. 東京 : 東京大学出版会 ; 1968. p.202.

 

P.191 掲載の参考文献

18) 岩田誠. 神経症候学を学ぶ人のために. 東京 : 医学書院 ; 1994.

 

19) Raina GB, Cersosimo MG, Folgar SS, et al. Holmes tremor : clinical description, lesion localization, and treatment in a series of 29 cases. Neurology. 2016 ; 86 : 931-8. [PMID : 26865524]

 

岩田誠. 振戦の病態力学. 神経進歩. 1985 ; 29 : 210-21.

 

岩田誠. 企図振戦. 神経内科. 1974 ; 1 : 397-409.

 

岩田誠. 小脳の症候学. In : 辻省次. 小脳と運動失調 小脳はなにをしているのか. 東京 : 中山書店 ; 2013. p.64-74.

 

P.192 掲載の参考文献

21) 井口正寛. ロベルト・シューマンの右手. 東京女子医科大学雑誌. 2014 ; 84 : E86-90.

 

22) Defazio G, Gigante AF, Abbruzzese G, et al. Tremor in primary adult-onset dystonia : prevalence and associated clinical features. J Neurol Neurosurg Psychiatry. 2013 ; 84 : 404-8. [PMID : 23142961]

 

P.194 掲載の参考文献

24) Jankovic J, Thomas M. Chapter 6 : psychogenic tremor and shaking. In : Hallett M, et al. Editors. Psychogenic movement disorders : neurology and neuropsychiatry. Philadelphia : Lippincott Williams & Wilkins ; 2006. p.41-7.

 

25) Espay AJ, Aybek S, Carson A, et al. Current concepts in diagnosis and treatment of functional neurological disorders. JAMA Neurol. 2018 ; 75 : 1132-41. [PMID : 29868890]

 

26) Mahajan R, Zachariah U. Images in clinical medicine. Wing-beating tremor. N Engl J Med. 2014 ; 371 : e1. [PMID : 24988588]

 

P.195 掲載の参考文献

27) Saifee TA, Schwingenschuh P, Reilly MM, et al. Tremor in inflammatory neuropathies. J Neurol Neurosurg Psychiatry. 2013 ; 84 : 1282-7. [PMID : 22952325]

 

P.196 掲載の参考文献

28) Hopfner F, Ahlf A, Lorenz D, et al. Early- and late-onset essential tremor patients represent clinically distinct subgroups. Mov Disord. 2016 ; 31 : 1560-6. [PMID : 27384030]

 

29) Hellmann MA, Melamed E, Steinmetz AP, et al. Unilateral lower limb rest tremor is not necessarily a presenting symptom of Parkinson's disease. Mov Disord. 2010 ; 25 : 924-7. [PMID : 20198647]

PubMed

P.197 掲載の参考文献

31) Lance JW, Adams RD. The syndrome of intention or action myoclonus as a sequel to hypoxic encephalopathy. Brain. 1963 ; 86 : 111-36. [PMID : 13928398

PubMed

P.198 掲載の参考文献

32) Benamer HTS, Patterson J, Grosset DG, et al. Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I] -FP-CIT SPECT imaging : The [123I] -FP-CIT study group. Mov Disord. 2000 ; 15 : 503-10. [PMID : 10830416]

 

P.199 掲載の参考文献

33) Doepp F, Plotkin M, Siegel L, et al. Brain parenchyma sonography and 123I-FP-CIT SPECT in Parkinson's disease and essential tremor. Mov Disord. 2008 ; 23 : 405-10. [PMID : 18067184]

 

34) Factor SA, Burkhard PR, Caroff S, et al. Recent developments in drug-induced movement disorders : a mixed picture. Lancet Neurol. 2019 ; 18 : 880-90. [PMID : 31279747]

 

Jesus-Ribeiro J, Freire A, Sargento-Freitas J, et al. Transcranial sonography and DaTSCAN in early stage Parkinson's disease and essential tremor. Eur Neurol. 2016 ; 76 : 252-5. [PMID : 27750247]

 

P.200 掲載の参考文献

1) Trohler U. William Cheselden's 1740 presentation of data on age-specific mortality after lithotomy. J R Soc Med. 2014 ; 107 : 165-6. [PMID : 24692412]

 

2) Brown JR, Thornton JL. Percivall Pott (1714-1788) and chimney sweepers' cancer of the scrotum. Br J Ind Med. 1957 ; 14 : 68-70. [PMID : 13396156]

 

3) Pott P. Farther remarks on the useless state of the lower limbs, in consequence of a curvature of the spine : being a supplement to a former treatise on that subject. 1782. Clin Orthop Relat Res. 2007 ; 460 : 4-9. [PMID : 17620803]

 

4) Fu L. Medicine and music : a note on John Hunter (1728-93) and Joseph Haydn (1732-1809). J Med Biogr. 2010 ; 18 : 115-22. [PMID : 20519713]

 

P.201 掲載の参考文献

7) Dunn PM. Dr William Hunter (1718-83) and the gravid uterus. Arch Dis Child Fetal Neonatal Ed. 1999 ; 80 : F76-7. [PMID : 10325820]

 

8) Khan IA, Mehta NJ. Initial historical descriptions of the angina pectoris. J Emerg Med. 2002 ; 22 : 295-8. [PMID : 11932097]

 

10) Hart FD. William Heberden, Edward Jenner, John Hunter and angina pectoris. J Med Biogr. 1995 ; 3 : 56-8. [PMID : 11640008]

 

11) Kligfield P. John Hunter, angina pectoris and medical education. Am J Cardiol. 1980 ; 45 : 367-9. [PMID : 6986748]

 

P.203 掲載の参考文献

14) Keith A. An inquiry into the nature of the skeletal changes in acromegaly. Lancet. 1911 ; 177 : 993-1002.

 

P.204 掲載の参考文献

16) Chahal HS, Stals K, Unterlander M, et al. AIP mutation in pituitary adenomas in the 18th century and today. N Engl J Med. 2011 ; 364 : 43-50. [PMID : 21208107]

 

17) JD Oriel. Eminent venereologists. 3. Philippe Ricord. Genitourin Med. 1989 ; 65 : 388-93. [PMID : 2693336]

 

18) 萬年甫. 動物の脳採集記 キリンの首をかつぐ話. 東京 : 中央公論新社 ; 1997.

 

Philippe Ricord (1800-1889), syphilographer. JAMA. 1970 ; 211 : 115-6. [PMID : 4902911]

 

P.205 掲載の参考文献

19) Currier RD. Did John Hunter give James Parkinson an idea? Arch Neurol. 1996 ; 53 : 377-8. [PMID : 8929162]

 

20) 「豊倉康夫, 編著. ジェイムズ・パーキンソンの人と業績-1755-1817 21世紀へ向けて. 診断と治療社 ; 2004」のp.15およびp.86より引用.

 

P.206 掲載の参考文献

23) クリストファー・G・ゲッツ, 編著. 加我牧子・鈴木文晴, 監訳. シャルコー 神経学講義. 白楊社 ; 1999年

 

24) アンドレ・ブルトン. 巌谷國士, 訳. シュルレアリスム宣言・溶ける魚, 岩波文庫. 1992.

 

アンドレ・ブルトン. 巌谷國士, 訳. ナジャ. 岩波文庫. 2003.

 

P.208 掲載の参考文献

三浦謹之助の生家. http://neurology-fukushima.com/

 

ウェンディ・ムーア. 矢野真千子, 訳. 解剖医ジョン・ハンターの数奇な生涯. 東京 : 河出書房 ; 2013.

 

Goddard J. The knife man : the extraordinary life and times of John Hunter, father of modern surgery. J R Soc Med. 2005 ; 98 : 335. [PMCID : PMC1168927]

 

Kaya Y, Sindel A. John Hunter (1728-1793) and his legacy to science. Childs Nerv Syst. 2016 ; 32 : 1015-7. [PMID : 26243161]

 

岩田誠. ペール・ラシェーズの医学者たち. 東京 : 中山書店 ; 1995.

 

高橋昭. 50周年記念講演 日本神経学会-誕生と発展-. 臨床神経. 2009 ; 49 : 724-30.

 

各論5 しびれ感

P.214 掲載の参考文献

3) Chen WH, Li TH, Chen TH, et al. Crossed cheiro-oral syndrome. Clin Neurol Neurosurg. 2008 ; 110 : 1008-11. [PMID : 18667266]

 

6) Mori K, Iijima M, Koike H, et al. The wide spectrum of clinical manifestations in Sjogren's syndrome-associated neuropathy. Brain. 2005 ; 128 : 2518-34. [PMID : 16049042]

 

7) Dumas M, Perusse R. Trigeminal sensory neuropathy : a study of 35 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999 ; 87 : 577-82. [PMID : 10348516]

 

Penarrocha M, Cervello MA, Marti E, et al. Trigeminal neuropathy. Oral Dis. 2007 ; 13 : 141-50. [PMID : 17305614]

 

P.215 掲載の参考文献

8) 標準的神経治療 : 手根管症候群 https://www.jsnt.gr.jp/guideline/img/syukonkan.pdf

 

9) Matsumoto M, Fujimura Y, Suzuki N, et al. MRI of cervical intervertebral discs in asymptomatic subjects. J Bone Joint Surg Br. 1998 ; 80 : 19-24. [PMID : 9460946]

 

P.216 掲載の参考文献

12) https://minds.jcqhc.or.jp/n/med/4/med0017/G0000309/0012

 

P.217 掲載の参考文献

14) Petrie A, Tubbs RS, Matusz P, et al. Obturator hernia : anatomy, embryology, diagnosis, and treatment. Clin Anat. 2011 ; 24 : 562-9. [PMID : 21322061]

 

15) Ropper AH, Zafonte RD. Sciatica. N Engl J Med. 2015 ; 372 : 1240-8. [PMID : 25806916]

 

P.219 掲載の参考文献

21) 安藤哲. 頸椎症の診療. 臨床神経. 2012 ; 52 : 469-79. https://www.neurology-jp.org/Journal/public_pdf/052070469.pdf

 

P.222 掲載の参考文献

25) 下津浦宏之, 井上聖啓. 認定医-指導医のためのレビュー・オピニオン デルマトーム図. 脊椎外科. 2012 ; 26 : 147-61.

 

P.226 掲載の参考文献

28) MacDermid JC, Wessel J. Clinical diagnosis of carpal tunnel syndrome : a systematic review. J Hand Ther. 2004 ; 17 : 309-19. [PMID : 15162113]

 

29) Graham B, Peljovich AE, Afra R, et al. The American Academy of Orthopaedic Surgeons Evidence-Based Clinical Practice Guideline on : Management of Carpal Tunnel Syndrome. J Bone Joint Surg Am. 2016 ; 98 : 1750-4. [PMID : 27869627]

 

P.229 掲載の参考文献

33) Spinner RJ, Poliakoff MB, Tiel RL. The origin of "Saturday night palsy"? Neurosurgery. 2002 ; 51 : 737-41 [PMID : 12188953]

 

Saccenti E, Smilde AK, Saris WH. Beethoven's deafness and his three styles. BMJ. 2011 ; 343 : d7589 [PMID : 22187391]

 

P.230 掲載の参考文献

34) 朝日新聞ウィークリーAERA「SMプレイの一般化・低年齢化がもたらした思わぬ「被害」とは…」. https://dot.asahi.com/aera/2016062300241.html?page=2

 

35) Harney D, Patijn J. Meralgia paresthetica : diagnosis and management strategies. Pain Med. 2007 ; 8 : 669-77. [PMID : 18028045]

 

36) Khalil N, Nicotra A, Rakowicz W. Treatment for meralgia paraesthetica. Cochrane Database Syst Rev. 2012 ; 12 : CD004159. [PMID : 23235604]

 

P.235 掲載の参考文献

44) Bansal V, Kalita J, Misra UK. Diabetic neuropathy. Postgrad Med J. 2006 ; 82 : 95-100. [PMID : 16461471]

 

45) Koike H, Takahashi M, Ohyama K, et al. Clinicopathologic features of folate-deficiency neuropathy. Neurology. 2015 ; 84 : 1026-33. [PMID : 25663227]

 

45) Stabler SP. Clinical practice. Vitamin B12 deficiency. N Engl J Med. 2013 ; 368 : 149-60. [PMID : 23301732]

 

46) England JD, Gronseth GS, Franklin G, et al. Practice parameter : evaluation of distal symmetric polyneuropathy : role of laboratory and genetic testing (an evidence-based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation. Neurology. 2009 ; 72 : 185-92. [PMID : 19056666]

 

P.236 掲載の参考文献

47) Reynolds E. Vitamin B12, folic acid, and the nervous system. Lancet Neurol. 2006 ; 5 : 949-60. [PMID : 17052662]

 

48) Xiao CP, Ren CP, Cheng JL, et al. Conventional MRI for diagnosis of subacute combined degeneration (SCD) of the spinal cord due to vitamin B-12 deficiency. Asia Pac J Clin Nutr. 2016 ; 25 : 34-8. [PMID : 26965759]

 

49) Kumar N, Gross JB Jr, Ahlskog JE. Copper deficiency myelopathy produces a clinical picture like subacute combined degeneration. Neurology. 2004 ; 63 : 33-9. [PMID : 15249607]

 

50) https://www.yakuji.co.jp/entry18354.html

 

51) Patel NJ, Bradshaw MJ, Birchmore DA. Hypocupremia secondary to excessive zinc supplementation and gastric surgery. Neurol Clin Pract. 2015 ; 5 : 512-4. [PMID : 29595819]

 

P.237 掲載の参考文献

52) Koike H, Misu K, Hattori N, et al. Postgastrectomy polyneuropathy with thiamine deficiency. J Neurol Neurosurg Psychiatry. 2001 ; 71 : 357-62. [PMID : 11511711]

 

54) Julian T, Glascow N, Syeed R, et al. Alcohol-related peripheral neuropathy : a systematic review and meta-analysis. J Neurol. 2019 ; 266 : 2907-19. [PMID : 30467601]

 

55) Beghi E, Delodovici ML, Bogliun G, et al. Hypothyroidism and polyneuropathy. J Neurol Neurosurg Psychiatry. 1989 ; 52 : 1420-3. [PMID : 2559162]

 

56) Duyff RF, Van den Bosch J, Laman DM, et al. Neuromuscular findings in thyroid dysfunction : a prospective clinical and electrodiagnostic study. J Neurol Neurosurg Psychiatry. 2000 ; 68 : 750-5. [PMID : 10811699]

 

57) Shiri R. Hypothyroidism and carpal tunnel syndrome : a meta-analysis. Muscle Nerve. 2014 ; 50 : 879-83. [PMID : 25204641]

 

P.238 掲載の参考文献

59) Stevens O, Claeys KG, Poesen K, et al. Diagnostic challenges and clinical characteristics of hepatitis E virus-associated Guillain-Barre syndrome. JAMA Neurol. 2017 ; 74 : 26-33. [PMID : 27820624]

 

60) Gold CA, Josephson SA. Anticipating the challenges of Zika virus and the Incidence of Guillain-Barre syndrome. JAMA Neurol. 2016 ; 73 : 905-6 [PMID : 27272118]

 

61) Tan CY, Razali SNO, Goh KJ, et al. Association of dengue infection and Guillain-Barre syndrome in Malaysia. J Neurol Neurosurg Psychiatry. 2019. [Epub ahead of print] [PMID : 31085583]

 

62) Willison HJ, Jacobs BC, van Doorn PA. Guillain-Barre syndrome. Lancet. 2016 ; 388 : 717-27. [PMID : 26948435]

 

Fukae J, Tsugawa J, Ouma S, et al. Guillain-Barre and Miller Fisher syndromes in patients with anti-hepatitis E virus antibody : a hospital-based survey in Japan. Neurol Sci. 2016 ; 37 : 1849-51. [PMID : 27389141]

 

Uncini A, Shahrizaila N, Kuwabara S. Zika virus infection and Guillain-Barre syndrome : a review focused on clinical and electrophysiological subtypes. J Neurol Neurosurg Psychiatry. 2017 ; 88 : 266-71 [PMID : 27799296]

 

P.241 掲載の参考文献

67) Misawa S, Kuwabara S, Sato Y, et al. Safety and efficacy of eculizumab in Guillain-Barre syndrome : a multicentre, double-blind, randomised phase 2 trial. Lancet Neurol. 2018 ; 17 : 519-29. [PMID : 29685815]

 

P.247 掲載の参考文献

69) Iguchi M, Hashiguchi A, Ito E, et al. Charcot-Marie-Tooth disease type 4C in Japan : report of a case. Muscle Nerve. 2013 ; 47 : 283-6. [PMID : 23281072]

 

P.248 掲載の参考文献

71) Hu Y, Kim HI, Hyung WJ. Vitamin B (12) deficiency after gastrectomy for gastric cancer : an analysis of clinical patterns and risk factors. Ann Surg. 2013 ; 258 : 970-5. [PMID : 24096753]

 

Adachi S, Kawamoto T, Otsuka M, et al. Enteral vitamin B12 supplements reverse postgastrectomy B12 deficiency. Ann Surg. 2000 ; 232 : 199-201. [PMID : 10903597]

 

P.249 掲載の参考文献

73) Hedenmalm K, Spigset O. Peripheral sensory disturbances related to treatment with fluoroquinolones. J Antimicrob Chemother. 1996 ; 37 : 831-7. [PMID : 8722551]

 

Morales D, Pacurariu A, Slattery J, et al. Association between peripheral neuropathy and exposure to oral fluoroquinolone or amoxicillin-clavulanate therapy. JAMA Neurol. 2019 ; 76 : 827-33. [PMID : 31034074]

PubMed

P.251 掲載の参考文献

(2) 反射の検査(ロバート・ワルテンベルグ. 佐野圭司, 訳. 医学書院)

 

74) (1) 神経学の源流1 ババンスキーとともに-(萬年 甫, 訳編, 東京大学出版会)

 

75) Holmoy T. The discovery of oligoclonal bands : a 50-year anniversary. Eur Neurol. 2009 ; 62 : 311-5. [PMID : 19729928]

 

75) 生化夜話 第14回 : あの調味料と等電点電気泳動. https://www.gelifesciences.co.jp/newsletter/biodirect_mail/chem_story/86.html

 

P.252 掲載の参考文献

77) Kahn SN, Bina M. Sensitivity of immunofixation electrophoresis for detecting IgM paraproteins in serum. Clin Chem. 1988 ; 34 : 1633-5. [PMID : 3135960]

 

P.255 掲載の参考文献

Sansone JM, Gatzke AM, Aslinia F, et al. Jules Tinel (1879-1952) and Paul Hoffman (1884-1962). Clin Med Res. 2006 ; 4 : 85-9. [PMID : 16718952]

 

Davis EN, Chung KC. The Tinel sign : a historical perspective. Plast Reconstr Surg. 2004 ; 114 : 494-9. [PMID : 15277821]

 

Phalen GS. The carpal-tunnel syndrome. Seventeen years' experience in diagnosis and treatment of six hundred fifty-four hands. J Bone Joint Surg Am. 1966 ; 48 : 211-28. [PMID : 5934271]

 

Hoffmann P. On a Method of Evaluating the Success of a Nerve Suture. Arch Neurol. 1971 ; 24 : 573-4.

 

Tinel J. The sign of "Tingling" in lesions of the peripheral nerves. Arch Neurol. 1971 ; 24 : 574-5.

 

書評を投稿する